Galectin Therapeutics Inc (GALT): Cash & Equivalents
$17.72M
As of 2025-12-31
$13.27M
As of 2026-06-30
-1.6%
3-year compound annual growth
-8.2%
5-year compound annual growth
-3.7%
10-year compound annual growth
| Period ended | Cash & Equivalents | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $17.72M | +17.2% | 2026-03-31, Balance as of period end |
| 2024-12-31 | $15.12M | -41.1% | 2026-03-31, Balance as of period end |
| 2023-12-31 | $25.66M | +38.0% | 2025-03-31, Balance as of period end |
| 2022-12-31 | $18.59M | -53.1% | 2024-03-29, Balance as of period end |
| 2021-12-31 | $39.65M | +46.1% | 2023-03-30, Balance as of period end |
| 2020-12-31 | $27.14M | -42.8% | 2022-03-31, Balance as of period end |
| 2019-12-31 | $47.48M | +475.3% | 2021-03-31, Balance as of period end |
| 2018-12-31 | $8.25M | +170.3% | 2020-03-16, Balance as of period end |
| 2017-12-31 | $3.05M | -80.1% | 2019-03-06, Balance as of period end |
| 2016-12-31 | $15.36M | -40.6% | 2018-03-29, Balance as of period end |
| 2015-12-31 | $25.85M | -11.3% | 2017-03-28, Balance as of period end |
| 2014-12-31 | $29.13M | +177.7% | 2016-03-15, Balance as of period end |
| 2013-12-31 | $10.49M | +12.0% | 2016-03-15, Balance as of period end |
| 2012-12-31 | $9.36M | +46.4% | 2015-03-18, Balance as of period end |
| 2011-12-31 | $6.40M | +8.6% | 2013-03-29, Balance as of period end |
| 2010-12-31 | $5.89M | n/a | 2012-03-30, Balance as of period end |
Cash & Equivalents at similar companies
| Company | Year ended | Cash & Equivalents | Change YoY |
|---|---|---|---|
| Galectin Therapeutics Inc (GALT) | 2025-12-31 | $17.72M | +17.2% |
| Lftd Partners Inc. (LIFD) | 2025-12-31 | $1.77M | -17.7% |
| Marker Therapeutics, Inc. (MRKR) | 2025-12-31 | $16.07M | -16.3% |
| Genelux Corp (GNLX) | 2025-12-31 | $5.33M | -37.7% |
| Evofem Biosciences, Inc. (EVFM) | 2025-12-31 | $578.0K | -22.0% |
| Quoin Pharmaceuticals Ltd. (QNRX) | 2025-12-31 | $3.82M | +5.4% |
| Nexentis Technologies Inc. (NXTS) | 2025-12-31 | $3.83M | +99.3% |
| Incannex Healthcare Inc. (IXHL) | 2025-06-30 | $15.04M | +156.7% |
| Galmed Pharmaceuticals Ltd. (EOCN) | 2025-12-31 | $3.98M | -14.3% |
Compare GALT, LIFD, MRKR, GNLX side by side · Screen every company in Pharmaceutical Preparations ↗